CD133 Expression Predicts Relapse in Patients With Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemotherapy

Conclusion: CD133 expression may be a predictive biomarker for postoperative relapse in patients with LARC who received NAC before surgery.

Source: In Vivo - January 5, 2021 Category: Research Authors: OI, H., OKUYAMA, T., MIYAZAKI, S., ONO, Y., OYA, M. Tags: Clinical Studies Source Type: research